These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10147349)

  • 21. NICE says no to inhaled insulin: what lessons should we learn?
    Freemantle N
    Pharmacoeconomics; 2006; 24(7):627-9. PubMed ID: 16802838
    [No Abstract]   [Full Text] [Related]  

  • 22. Do diabetic patients inject accurate doses of insulin?
    Kesson CM; Bailie GR
    Diabetes Care; 1981; 4(2):333. PubMed ID: 7011752
    [No Abstract]   [Full Text] [Related]  

  • 23. [Where is insulin disappearing? A study of dosage wastage in insulin-treated diabetics].
    Berne C; Agenäs I; Eriksson G; Wibell L
    Lakartidningen; 1983 Aug; 80(34):2989-93. PubMed ID: 6355711
    [No Abstract]   [Full Text] [Related]  

  • 24. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Real-world studies for answering real-world questions].
    Freemantle N
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S77-81. PubMed ID: 15988673
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plaster, tablet or inhalation? New dosage forms for insulin].
    von Susanne Heinzl B
    Med Monatsschr Pharm; 2006 Mar; 29(3):90-2. PubMed ID: 16550881
    [No Abstract]   [Full Text] [Related]  

  • 27. [Increasing cost of insulin therapy in Belgium. From a critical analysis of the situation to a search for practical solutions].
    Scheen AJ
    Rev Med Liege; 2006 Sep; 61(9):617-22. PubMed ID: 17112161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exit Exubera. Inhalable insulin is withdrawn due to weak sales.
    Keegan A
    Diabetes Forecast; 2007 Dec; 60(13):19. PubMed ID: 18217270
    [No Abstract]   [Full Text] [Related]  

  • 29. Healthcare reform in diabetes: more ranting about a broken system.
    Hirsch IB
    Diabetes Technol Ther; 2013 Mar; 15(3):212-3. PubMed ID: 23458366
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes.
    Bastian MD; Wolters NE; Bright DR
    Consult Pharm; 2011 Jun; 26(6):426-9. PubMed ID: 21628141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin. A comparison of commercial preparations].
    Menz W
    Med Monatsschr Pharm; 2006 Mar; 29(3):97-100. PubMed ID: 16550883
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes Clinical Care Conference: survival techniques in diabetes mellitus.
    J Tenn Med Assoc; 1981 Mar; 74(3):193-6, 196. PubMed ID: 7024645
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of insulin wastage in five Ontario hospitals.
    Rosenbloom D; Scime J; Elviss OD; Mayhew B; Thompson WJ; Thornley P; Wildeman M
    Can J Hosp Pharm; 1994 Feb; 47(1):5-7. PubMed ID: 10132676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing to U100 insulin.
    Moffitt P
    Aust Fam Physician; 1980 Oct; 9(10):737-40. PubMed ID: 7000057
    [No Abstract]   [Full Text] [Related]  

  • 35. Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India.
    Misra A; Mukherjee R; Luthra A; Singh P
    Diabetes Technol Ther; 2017 Dec; 19(12):693-698. PubMed ID: 29090974
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inhaled insulin, new perspective for insulin therapy].
    Radermecker RP; Sélam JL
    Rev Med Liege; 2005; 60(5-6):355-60. PubMed ID: 16035294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of diabetes. 7. Characteristics of the available insulins. Problems in insulin storage.
    Levine R; Mahler R; Moss JM
    Am Fam Physician GP; 1970 Nov; 2(5):151-63. PubMed ID: 5274324
    [No Abstract]   [Full Text] [Related]  

  • 38. Biosimilars for insulin: a cost-saving alternative?
    McCall C
    Lancet; 2018 Aug; 392(10146):463-464. PubMed ID: 30129449
    [No Abstract]   [Full Text] [Related]  

  • 39. [Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
    Lüddeke HJ
    MMW Fortschr Med; 2006 Sep; 148(37):9. PubMed ID: 17036893
    [No Abstract]   [Full Text] [Related]  

  • 40. Introducing insulin pen needle safety devices in Australia to protect nurses.
    Gillespie E; Canning E
    Aust Nurs Midwifery J; 2014 Jul; 22(1):30-3. PubMed ID: 25090881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.